Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 151–200 of 217 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07153068	SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies	recruiting	Phase 1 / Phase 2	12	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Dec 15, 2025	clinicaltrials
NCT04787263	CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML	active not recruiting	Phase 1 / Phase 2	32	Bambino Gesù Hospital and Research InstituteOTHER	1	Dec 2, 2025